Shrikanth A.G. Reddy
- Molecular Biology top 10%
- Oncology top 5%
- Cancer Research top 5%
- Immunology top 10%
- Molecular Medicine top 5%
- Co-authors
- Warren S.‐L. LiaoJianyi H. HuangBharat B. AggarwalJames L. AbbruzzeseYixin YaoTakayuki AsanoDonghui LiJijiang Zhu
- Topics
- PI3K/AKT/mTOR signaling in cancer (10 papers)Immune Response and Inflammation (4 papers)NF-κB Signaling Pathways (4 papers)
- Partner nations
- United StatesAustraliaSingapore
In The Last Decade
Shrikanth A.G. Reddy
23 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 97
- Molecular Biology 953
- Oncology 562
- Cancer Research 456
- Immunology 297
- Molecular Medicine 129
Countries citing papers authored by Shrikanth A.G. Reddy
This map shows the geographic impact of Shrikanth A.G. Reddy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shrikanth A.G. Reddy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shrikanth A.G. Reddy more than expected).
Fields of papers citing papers by Shrikanth A.G. Reddy
This network shows the impact of papers produced by Shrikanth A.G. Reddy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shrikanth A.G. Reddy. The network helps show where Shrikanth A.G. Reddy may publish in the future.
Co-authorship network of co-authors of Shrikanth A.G. Reddy
This figure shows the co-authorship network connecting the top 25 collaborators of Shrikanth A.G. Reddy. A scholar is included among the top collaborators of Shrikanth A.G. Reddy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shrikanth A.G. Reddy. Shrikanth A.G. Reddy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 70 | |
| 2 | 141 | |
| 3 | 21 | |
| 4 | 15 | |
| 5 | 34 | |
| 6 | 29 | |
| 7 | Role of the PI3K/Akt pathway in promoting drug resistance of human pancreatic cells | 1 |
| 8 | 18 | |
| 9 | 57 | |
| 10 | 12 | |
| 11 | 247 | |
| 12 | 60 | |
| 13 | 50 | |
| 14 | 76 | |
| 15 | 161 | |
| 16 | 37 | |
| 17 | 8 | |
| 18 | 217 | |
| 19 | 193 | |
| 20 | 3 |
About Shrikanth A.G. Reddy
Shrikanth A.G. Reddy is a scholar working on Cancer Research, Oncology and Toxicology, having authored 23 papers that have together received 1.6k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (10 papers), Immune Response and Inflammation (4 papers) and NF-κB Signaling Pathways (4 papers). The work is most often cited by research in Cancer Research (456 citations), Molecular Medicine (129 citations) and Oncology (562 citations). Shrikanth A.G. Reddy has collaborated with scholars based in United States, Australia and Singapore. Frequent co-authors include Warren S.‐L. Liao, Jianyi H. Huang, Bharat B. Aggarwal, James L. Abbruzzese, Yixin Yao, Takayuki Asano, Donghui Li, Jijiang Zhu, David G. Menter and W.K. Alfred Yung. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.